Лихорадка долины Рифт

Patterson M, Grant A, Paessler S. Epidemiology and pathogenesis of Bolivian hemorrhagic fever. Curr Opin Virol. 2014;5:82-90.Полный текст  Аннотация

Gómez RM, Jaquenod de Giusti C, Sanchez Vallduvi MM, et al. Junín virus. A XXI century update. Microbes Infect. 2011;13:303-311. Аннотация

Enria DA, Briggiler AM, Sánchez Z. Treatment of Argentine hemorrhagic fever. Antiviral Res. 2008;78:132-139. Аннотация

Enria DA, Briggiler AM, Feuillade MR. An overview of the epidemiological, ecological and preventive hallmarks of Argentine haemorrhagic fever (Junin virus). Bulletin Institut Pasteur. 1998;96:103-114.

de Manzione N, Salas RA, Paredes H, et al. Venezuelan hemorrhagic fever: clinical and epidemiological studies of 165 cases. Clin Infect Dis. 1998;26:308-313.Полный текст  Аннотация

Delgado S, Erickson BR, Agudo R, et al. Chapare virus, a newly discovered arenavirus isolated from a fatal hemorrhagic fever case in Bolivia. PLoS Pathog. 2008;4:e1000047.Полный текст  Аннотация

Grant A, Seregin A, Huang C, et al. Junín virus pathogenesis and virus replication. Viruses. 2012;4:2317-2339.Полный текст  Аннотация

1. Patterson M, Grant A, Paessler S. Epidemiology and pathogenesis of Bolivian hemorrhagic fever. Curr Opin Virol. 2014;5:82-90.Полный текст  Аннотация

2. Gómez RM, Jaquenod de Giusti C, Sanchez Vallduvi MM, et al. Junín virus. A XXI century update. Microbes Infect. 2011;13:303-311. Аннотация

3. Enria DA, Briggiler AM, Sánchez Z. Treatment of Argentine hemorrhagic fever. Antiviral Res. 2008;78:132-139. Аннотация

4. Enria DA, Briggiler AM, Feuillade MR. An overview of the epidemiological, ecological and preventive hallmarks of Argentine haemorrhagic fever (Junin virus). Bulletin Institut Pasteur. 1998;96:103-114.

5. de Manzione N, Salas RA, Paredes H, et al. Venezuelan hemorrhagic fever: clinical and epidemiological studies of 165 cases. Clin Infect Dis. 1998;26:308-313.Полный текст  Аннотация

6. Delgado S, Erickson BR, Agudo R, et al. Chapare virus, a newly discovered arenavirus isolated from a fatal hemorrhagic fever case in Bolivia. PLoS Pathog. 2008;4:e1000047.Полный текст  Аннотация

7. Barry M, Russi M, Armstrong L, et al. Brief report: treatment of a laboratory-acquired Sabiá virus infection. N Engl J Med. 1995;333:294-296.Полный текст  Аннотация

8. Centers for Disease Control and Prevention. Viral hemorrhagic fevers (VHFs): Old World/New World arenaviruses. June 2013 [internet publication].Полный текст

9. Grant A, Seregin A, Huang C, et al. Junín virus pathogenesis and virus replication. Viruses. 2012;4:2317-2339.Полный текст  Аннотация

10. Centers for Disease Control and Prevention. Viral hemorrhagic fevers (VHFs): arenaviridae. June 2013 [internet publication].Полный текст

11. Mackenzie RB. Epidemiology of Machupo virus infection. I. Pattern of human infection, San Joaquín, Bolivia, 1962-1964. Am J Trop Med Hyg. 1965;14:808-813. Аннотация

12. Garrett L. The coming plague: newly emerging diseases in a world out of balance. New York, NY: Farrar, Straus and Giroux; 1994.

13. Escalera-Antezana JP, Rodriguez-Villena OJ, Arancibia-Alba AW, et al. Clinical features of fatal cases of Chapare virus hemorrhagic fever originating from rural La Paz, Bolivia, 2019: A cluster analysis. Travel Med Infect Dis. 2020 Jul - Aug;36:101589. Аннотация

14. Fulhorst CF, Bowen MD, Salas RA, et al. Natural rodent host associations of Guanarito and pirital viruses (Family Arenaviridae) in central Venezuela. Am J Trop Med Hyg. 1999;61:325-330.Полный текст  Аннотация

15. Abraham J, Corbett KD, Farzan M, et al. Structural basis for receptor recognition by New World hemorrhagic fever arenaviruses. Nat Struct Mol Biol. 2010;17:438-444.Полный текст  Аннотация

16. Zinzula L, Tramontano E. Strategies of highly pathogenic RNA viruses to block dsRNA detection by RIG-I-like receptors: hide, mask, hit. Antiviral Res. 2013;100:615-635. Аннотация

17. Xing J, Ly H, Liang Y. The Z proteins of pathogenic but not nonpathogenic arenaviruses inhibit RIG-I-like receptor-dependent interferon production. J Virol. 2015;89:2944-2955.Полный текст  Аннотация

18. Fan L, Briese T, Lipkin WI. Z proteins of new world arenaviruses bind RIG-I and interfere with type I interferon induction. J Virol. 2010;84:1785-1791.Полный текст  Аннотация

19. Marta RF, Montero VS, Hack CE, et al. Proinflammatory cytokines and elastase-alpha-1-antitrypsin in Argentine hemorrhagic fever. Am J Trop Med Hyg. 1999;60:85-89.Полный текст  Аннотация

20. World Health Organization. Guidance: steps to remove personal protective equipment. 2014 [internet publication].Полный текст

21. World Health Organization. Guidance: steps to put on personal protective equipment. 2014 [internet publication].Полный текст

22. Centers for Disease Control and Prevention. Guidance on personal protective equipment (PPE) to be used by healthcare workers during management of patients with confirmed Ebola or persons under investigation (PUIs) for Ebola who are clinically unstable or have bleeding, vomiting, or diarrhea in US hospitals, including procedures for donning and doffing PPE. August 2018 [internet publication].Полный текст

23. UK Department of Health. Management of Hazard Group 4 viral haemorrhagic fevers and similar human infectious diseases of high consequence. November 2015 [internet publication].Полный текст

24. Olschläger S, Flatz L. Vaccination strategies against highly pathogenic arenaviruses: the next steps toward clinical trials. PLoS Pathog. 2013;9:e1003212.Полный текст  Аннотация

25. Kerber R, Reindl S, Romanowski V, et al. Research efforts to control highly pathogenic arenaviruses: a summary of the progress and gaps. J Clin Virol. 2015;64:120-127. Аннотация

26. Leligdowicz A, Fischer WA 2nd, Uyeki TM, et al. Ebola virus disease and critical illness. Crit Care. 2016;20:217. Аннотация

27. Enria D, Mills JN, Bausch D, et al. Arenavirus infections. In: Guerrant RL, Walker DH, Weller PF, eds. Tropical infectious diseases: principles, pathogens, and practice. 3rd ed. Amsterdam: Elsevier; 2011:449-461.

28. Salazar M, Yun NE, Poussard AL, et al. Effect of ribavirin on Junin virus infection in guinea pigs. Zoonoses Public Health. 2012;59:278-285. Аннотация

29. Kilgore PE, Ksiazek TG, Rollin PE, et al. Treatment of Bolivian hemorrhagic fever with intravenous ribavirin. Clin Infect Dis. 1997;24:718-722.Полный текст  Аннотация

30. Mendenhall M, Russell A, Juelich T, et al. T-705 (favipiravir) inhibition of arenavirus replication in cell culture. Antimicrob Agents Chemother. 2011;55:782-787.Полный текст  Аннотация

31. Gowen BB, Juelich TL, Sefing EJ, et al. Favipiravir (T-705) inhibits Junín virus infection and reduces mortality in a guinea pig model of Argentine hemorrhagic fever. PLoS Negl Trop Dis. 2013;7:e2614.Полный текст  Аннотация

32. Sissoko D, Laouenan C, Folkesson E, et al. Experimental treatment with favipiravir for Ebola virus disease (the JIKI trial): a historically controlled, single-arm proof-of-concept trial in Guinea. PLoS Med. 2016;13:e1001967.Полный текст  Аннотация

33. Veliziotis I, Roman A, Martiny D, et al. Clinical management of Argentine hemorrhagic gever using ribavirin and favipiravir, Belgium, 2020. Emerg Infect Dis. 2020 Jul;26(7):1562-6.Полный текст  Аннотация

34. Vela E. Animal models, prophylaxis, and therapeutics for arenavirus infections. Viruses. 2012;4:1802-1829.Полный текст  Аннотация

35. Gowen BB, Smee DF, Wong MH, et al. Combinatorial ribavirin and interferon alfacon-1 therapy of acute arenaviral disease in hamsters. Antivir Chem Chemother. 2006;17:175-183. Аннотация

36. Gowen BB, Barnard DL, Smee DF, et al. Interferon alfacon-1 protects hamsters from lethal pichinde virus infection. Antimicrob Agents Chemother. 2005;49:2378-2386.Полный текст  Аннотация

37. York J, Dai D, Amberg SM, et al. pH-induced activation of arenavirus membrane fusion is antagonized by small-molecule inhibitors. J Virol. 2008;82:10932-10939.Полный текст  Аннотация

38. Bolken TC, Laquerre S, Zhang Y, et al. Identification and characterization of potent small molecule inhibitor of hemorrhagic fever New World arenaviruses. Antiviral Res. 2006;69:86-97. Аннотация

39. Lavanya M, Cuevas CD, Thomas M, et al. siRNA screen for genes that affect Junín virus entry uncovers voltage-gated calcium channels as a therapeutic target. Sci Transl Med. 2013;5:204ra131.Полный текст  Аннотация

40. Amanat F, Duehr J, Huang C, et al. Monoclonal antibodies with neutralizing activity and Fc-effector functions against the Machupo virus glycoprotein. J Virol. 2020 Feb 14;94(5):e01741-19.Полный текст  Аннотация

41. Pan X, Wu Y, Wang W, et al. Novel neutralizing monoclonal antibodies against Junin virus. Antiviral Res. 2018 Aug;156:21-8. Аннотация

42. Zeitlin L, Geisbert JB, Deer DJ, et al. Monoclonal antibody therapy for Junin virus infection. Proc Natl Acad Sci U S A. 2016 Apr 19;113(16):4458-63.Полный текст  Аннотация

43. Mapp Biopharmaceutical. LeafBio announces conclusion of ZMapp™ clinical trial. February 2016 [internet publication].Полный текст

44. Kolokoltsova OA, Yun NE, Paessler S. Reactive astrogliosis in response to hemorrhagic fever virus: microarray profile of Junin virus-infected human astrocytes. Virol J. 2014;11:126.Полный текст  Аннотация

45. McLay L, Liang Y, Ly H. Comparative analysis of disease pathogenesis and molecular mechanisms of New World and Old World arenavirus infections. J Gen Virol. 2014;95:1-15.Полный текст  Аннотация

46. Enría DA, Damilano AJ, Briggiler AM, et al. Sindrome neurologico tardio en enfermos de fiebre hemorrágica Argentina tratados con plasma immune. Medicina (Buenos Aires). 1985;45:615-620.

47. Melcon MO, Herskovits E. Complicaciones neurologicas tardias de la fiebre hemorragica argentina. Medicina (Buenos Aires). 1981;41:137-145.

48. Briggiler AM, Enria DA, Feuillade MR, et al. Contagio interhumano e infeccion inaparente por virus Junin in matrimonios del area endemica de fiebre hemorragica Argentina. Medicina (Buenos Aires). 1987;47:565.

49. Maiztegui JI, Fernandez NJ, de Damilano AJ. Efficacy of immune plasma in treatment of Argentine haemorrhagic fever and association between treatment and a late neurological syndrome. Lancet. 1979;2:1216-1217. Аннотация

50. Hadi CM, Goba A, Khan SH, et al. Ribavirin for Lassa fever postexposure prophylaxis. Emerg Infect Dis. 2010;16:2009-2011.Полный текст  Аннотация